Diabetes & Endocrinology

Diabetes & Endocrinology News

FDA Advisory Panel Endorses Semaglutide for Type 2 Diabetes UPDATED // Panel members give green light to semaglutide, say the benefits of HbA1c lowering and weight loss plus cardiovascular safety outweigh possible retinopathy risk.
Medscape Medical News, October 18, 2017

Calcium Essential to Limit Osteoporosis but Avoid Excess, Say Europeans Calcium levels of 700-1200 mg/day are recommended in postmenopausal women, but excessive doses could be harmful, highlights a new clinical guide from the European Menopause and Andropause Society.
Medscape Medical News, October 19, 2017
New Study Confirms Bariatric Surgery Lowers Cancer Risk in Women Bariatric surgery has again been shown to lower cancer risk in severely obese women compared with matched nonsurgical controls, primarily via a reduction in risk of obesity-specific carcinomas.
Medscape Medical News, October 18, 2017
Insulin Glargine/Breast Cancer Link Seen Again in Type 2 Diabetes A study in more than 22,000 women reports a weak signal of breast-cancer risk with insulin glargine vs NPH insulin, but the researchers caution that this should not change clinical practice.
Medscape Medical News, October 18, 2017
NAMS Osteoporosis Warrants Long-term Treatment Although bisphosphonate holidays can be part of the long-term management of osteoporosis, the concept does not transfer to all other drugs, an expert suggests.
Medscape Medical News, October 17, 2017

Tips for Demystifying Injections in Diabetes Dr Anne Peters demonstrates how she teaches injection techniques to patients with diabetes.
Medscape Diabetes & Endocrinology, October 12, 2017
The Data Show What I Expected… In the absence of definitive clinical guidance, confirmation bias may guide decision making.
Medscape Diabetes & Endocrinology, October 16, 2017
Walking the Path to Health Dr Henry Black speaks with cardiologist Paul Thompson on how the best exercise practices are often the simplest
Medscape Cardiology, September 20, 2016
Leading Science Journalist Carl Zimmer on His Genome Dr Eric Topol speaks with science journalist Carl Zimmer about where he gets his ideas, what his genome looks like, and how he got a tapeworm named after him.
Medscape, October 5, 2017
Reducing CV Risk in Diabetes: 'When' and 'How' Matter Reducing cardiovascular risk with glycemic control may depend on when and how it is achieved.
Medscape Diabetes & Endocrinology, July 19, 2017
Diabetes Technology: 'Fear Not' In the future, will the endocrinologist be more machine operator than physiology expert? Yes and no, says Dr Neinstein.
Medscape Diabetes & Endocrinology, June 21, 2017

Potentially Preventable Medicare Spending High in Frail Elderly Although frail elderly adults make up a small proportion of high-cost Medicare beneficiaries, they account for the greatest proportion of potentially preventable costs, a new study shows.
Medscape Medical News, October 19, 2017
Fewer ACA Ads, Puzzled Public Threaten Sign-ups, KFF Says
Medscape Medical News, October 19, 2017
'Robust Dialogue' Needed About Equity of Women in Healthcare
Medscape Medical News, October 18, 2017
Should Physicians Treat Gun Violence as a Public Health Threat?
Medscape Reader Polls, October 18, 2017

Should Doctors Embrace or Reject Alternative Treatments? More consumers are using complementary and alternative treatments, and medical centers are adding nontraditional therapies. Should doctors embrace or reject these treatments?
Medscape Business of Medicine, October 18, 2017
How Much Is Your Practice Worth? Many doctors who have a financial stake in a practice don't know what the practice is worth. That's a mistake, say experts in practice valuation. Here's why, and what a practice valuation involves.
Medscape Business of Medicine, October 17, 2017

Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape

CANVAS: Straight Talk Needed on Amputation Risk Can a meta-analysis of two different studies or data from observational studies overcome the clinical concern about the clear-cut amputation risk with canagliflozin seen in the CANVAS trial?
Medscape Diabetes & Endocrinology, October 16, 2017
Patient Prejudice: When Credentials Aren't Enough
Medscape Features Slideshows, October 18, 2017
The Data Show What I Expected…
Medscape Diabetes & Endocrinology, October 16, 2017
From Obese Kid to Practicing Physician: An MD’s Personal Story
Medscape Family Medicine, October 11, 2017